companydata.dkcompanydata.dk

OLANDER CLINICAL CONSULTING K/S: Financial statements 2022

CVR: 35860177

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

OLANDER CLINICAL CONSULTING K/S (CVR 35860177) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,919,291 and a net result of DKK 1,880,355 compared with DKK 1,758,667 the year before. That is an increase of 6.7% compared with the year before. Equity in the 2022 report amounted to DKK 621,486. The solvency ratio was 75.9%.

Gross Profit
DKK 1,919,291
Profit/Loss
DKK 1,880,355
Equity
DKK 621,486
Total Assets
DKK 818,336

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-1.9M1.9M621K-
2021-1.8M1.8M687K-
2020-1.5M1.5M461K-
2019-1.4M1.4M491K-
2018-1.7M1.7M700K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on OLANDER CLINICAL CONSULTING K/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

OLANDER CLINICAL CONSULTING K/S: The 2021 annual report is outJun 15, 2022

OLANDER CLINICAL CONSULTING K/S has published its annual report for 2021. Gross profit came to DKK 1,798,004, and the net result was DKK 1,758,667.

About OLANDER CLINICAL CONSULTING K/S

OLANDER CLINICAL CONSULTING K/S is a Danish company of the type Kommanditselskab based in Snekkersten, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Aae Olander. The company is owned by Birgitte Aae Olander. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 2,099,449 and a net result of DKK 2,057,637 compared with DKK 2,004,688 the year before. Equity in the 2025 report amounted to DKK 303,261.

Source: annual report 2025, Danish Business Authority